Figure 3: Expression of TBL1XR1 in stage I-III CRC patients and its clinical significance for disease-free survival.
From: Correlations between TBL1XR1 and recurrence of colorectal cancer
Reprehensive low expression (A–C) and high expression (D–F) of TBL1XR1 in tumor tissues from TNM stage I-III patients, respectively. (G) Patients with advanced TNM stage showed higher proportions of TBL1XR1 high expression (chi-square test, P = 0.019). (H) Quantification analyses of mean TBL1XR1 expression levels in tumor tissues from patients with different clinical stages. (I) Kaplan-Meier survival curves comparing cumulative disease-free survival rates in stage I-III patients with low and high TBL1XR1 expression levels. (J) Survival curves for CRC patients with clinical stage I-II. (K) Survival curves for non-chemotherapy CRC patients with TNM stage I-IV. Magnification: 200X. *Indicated statistical significance.
